Investor Overview

Webcast ImageWebcast
Q3 2017 HTG Molecular Diagnostics Inc Earnings Conference Call (Live)
11/07/17 at 4:30 p.m. ET
Q3 2017 HTG Molecular Diagnostics Inc Earnings Conference Call
Tuesday, November 7, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

HTG Molecular Diagnostics, Inc's. (“HTG”) mission is to empower precision medicine at the local level. In 2013, the company commercialized its HTG Edge instrument platform and a portfolio of multiplexed profiling panels that leverage HTG’s proprietary target protection chemistry. In 2014, the company launched the HTG EdgeSeq system that combines the power of HTG Edge chemistry and automation with NGS technology. The HTG EdgeSeq system enables fast and easy use of NGS instruments for molecular profiling.

Stock Quote

HTGM (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$2.25
Change (%) Stock is Down 0.01 (0.44%)
Volume211,808
Data as of 10/20/17 4:00 p.m. ET

Recent News

10/20/17
HTG Molecular Diagnostics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Tuesday, November 7
09/25/17
HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference
09/20/17
HTG Announces Issuance of Two Method Patents Related to its Technology
09/18/17
HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements
More News >>

Upcoming Events

11/07/17
Q3 2017 HTG Molecular Diagnostics Inc Earnings Conference Call

More Events >>
Data provided by Nasdaq. Minimum 15 minutes delayed.

Shareholder Tools

Print Page Print Page   E-mail Page E-mail Page   RSS Feeds RSS Feeds   E-mail Alerts E-mail Alerts